Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing
News
Annovis Bio Receives European Patent for Method of Treating Acute Nerve and Brain Insults
Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome’s COVID-19 Antibody Based Treatment
Annovis Bio’s Lead Candidate ANVS401 Improves Cognitive and Functional Outcomes in Stroke Mice Study
ENB Therapeutics Demonstrated Early Efficacy in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab
ENB-003 is the Company’s first in class small molecule therapeutic selectively targeting the ETB receptor – a novel immune checkpoint
Immunome’s Research Reveals a Broad Super Responder Memory B Cell Response to the SARS-CoV-2 Virus
Findings support the potential of Immunome’s approach to developing IMM-BCP-01 as an optimized antibody cocktail for the treatment and prophylaxis of COVID-19
Venatorx Pharmaceuticals Names New Head of Regulatory Affairs
Chitrananda Abeygunawardana, Ph.D. will lead the development and execution of Venatorx’s global regulatory strategy for its clinical and pre-clinical anti-infectives programs
Optimizing Nourishment in the NICU
The Connecticut Children’s Neonatal Intensive Care Unit at the UConn John Dempsey Hospital is offering a high-tech tool for moms to ensure their infants get the most out of breast milk and formula feeding.
Ride Health and COVID-19 Prevention Trials Network (CoVPN) Partner to Provide Transportation for Vaccine Trial Participants
Fred Hutchinson-led ‘harmonizer’ network for Operation Warp Speed vaccines leverages company’s COVID-equipped transportation network for five vaccines in Phase III clinical trials
Ride Health and ACTIV-2 Partner to Provide Transportation for Nationwide COVID-19 Therapeutic Study
NIH-funded Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2) study leveraging company’s COVID-19 equipped transportation network across dozens of sites nationwide